Has the BRCA Monopoly Been Reborn?

BRACAnalysis CDx’

Posts Tagged ‘BRACAnalysis CDx’’

Has the BRCA Monopoly Been Reborn?

A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time – at >$4000 a pop – in order to qualify for a new drug called Olaparib. Why? The FDA has approved PARP-inhibitor Olaparib for…

Read More